Answers are grounded in this paper and cite their sources.
The purpose of our study was to assess the differential activity of TRPV1 channels to curcumin and nanocurcumin in middle uterine artery (MUA) obtained from non-pregnant (NP) and pregnant (P) Capra hircus (Ch). MUA rings were mounted in an automatic organ bath containing 20 ml MKHS, maintained at pH 7.4. Vasorelaxation of curcumin (CUR) and nanocurcumin (NCUR) in presence and absence of TRPV1 antagonists in PE-precontracted MUA were elicited. The responses were recorded isometrically by highly sensitive isometric force transducer automatic organ bath connected to powerlab and analysed using Lab chart 7.1.3 software.The maximal vasorelaxation in PE-precontracted ED + MUA rings with curcumin and nanocurcumin (1pM-100 M) was NP 42.58%, 40.36% and P Ch 55.49%, 44.09%, respectively. Capsazepine (CAPZ), and ruthenium red (RR) attenuated curcumin-induced vasorelaxation (CVR) to 27.81 0.42%, 13.77 1.78 % in NP and to 24.17 0.26%, 29.24 0.81% in P Ch, respectively. Similarly, CAPZ and RR attenuated nanocurcumin-induced vasorelaxation (NCVR) to 24.54 0.94%, 25.61 2.33% in NP and to 23.95 0.45%, 34.05 1.32% in P Ch. (i) The vasorelaxation of MUA of Ch is mediated by curcumin and nanocurcumin via differential activation of TRPV1 channel, (ii) Sensitivity of TRPV1 to curcumin is significantly greater than nanocurcumin in MUA of both NP and P Ch, (iii) Curcumin and nanocurcumin could be useful to control hypertension during pregnancy.
No takes yet. Share an insight, caveat, or question.
Parija et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: